Back to trial detailsIntake questionnaire
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Applying to Accurate Clinical Research · Lake Charles, Louisiana
Answer a few short questions to share with the research team.
0 of 4 answered